Evoke (LON:EVOK) Trading Down 18.3% – Should You Sell?

Shares of Evoke plc (LON:EVOKGet Free Report) fell 18.3% during trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.30 ($0.75). 8,720,666 shares were traded during mid-day trading, an increase of 322% from the average session volume of 2,066,078 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analysts Set New Price Targets

EVOK has been the subject of a number of research reports. Berenberg Bank decreased their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research report on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a report on Monday, December 16th.

Check Out Our Latest Analysis on EVOK

Evoke Stock Performance

The stock has a market capitalization of £224.78 million, a price-to-earnings ratio of -1.26 and a beta of 0.84. The firm’s 50 day moving average is GBX 68.88 and its 200-day moving average is GBX 63.49.

Evoke (LON:EVOKGet Free Report) last posted its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, sell-side analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Buying and Selling at Evoke

In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by corporate insiders.

About Evoke

(Get Free Report)

See Also

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.